Activation navigation mobile
Scientific & Medical Advisors
Partners & Support
Our scientific approach
Main scientific publications
GlioCure finalises its seed capital with a financing from « French Tech Seed » and reports a second consecutive profitable year.
Publié le Tuesday 12 May 2020
Angers, May 12th, 2020 – GlioCure SAS, a biotech company specialised in neuro-oncology,...
RELIEF, a strategic project for GlioCure, selected by EUREKA!
Publié le Tuesday 21 January 2020
Angers, France - GlioCure SAS, a biotechnology company specialized in neuro-oncology,...
GlioCure receives the "Seal of Excellence" from the European Commission
Publié le Friday 21 June 2019
GlioCure was awarded the "Seal of Excellence" under the H2020 Instrument PME phase 1 scheme for...
Merck Awards Grants to Biotechs Tackling Cancer and Cardiovascular Disease
Publié le Monday 4 February 2019
Three European companies to use Merck’s Advance Biotech Grant prizes to accelerate...
An eminent oncologist joins the GlioCure Scientific and Medical Advisory Board
Publié le Thursday 6 July 2017
Dr. Jean-Pierre BIZZARI, world renowned expert in oncology, is joining GlioCure's Scientific and...